My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
TEVA
Clerk
>
Contracts / Agreements
>
T
>
TEVA
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/12/2023 3:24:36 PM
Creation date
4/12/2023 3:24:11 PM
Metadata
Fields
Template:
Contracts
Company Name
TEVA
Contract #
A-2023-060-02
Agency
City Attorney's Office
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
12
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: B15AAEBD-74AB-4EFF-B97F-0776E33BOD86 <br />g) Walmart Settlement Agreement means the Walmart Settlement Agreement dated <br />November 14, 2022, and any revision thereto. <br />h) CA Litigating Special District means a Litigating Special District located in <br />California. CA Litigating Special Districts include Downey Unified School District, <br />Elk Grove Unified School District, Kern High School District, Montezuma Fire <br />Protection District (located in Stockton, California), Santa Barbara San Luis Obispo <br />Regional Health Authority, Inland Empire Health Plan, Health Plan of San Joaquin, <br />San Leandro Unified School District, Pleasant Valley School District Board, and <br />LA Care Health Plan. <br />i) Plaintiff Subdivision means a Subdivision located in California, other than a CA <br />Litigating Special District, that filed a lawsuit, on behalf of the Subdivision and/or <br />through an official of the Subdivision on behalf of the People of the State of <br />California, against one or more Opioid Defendants prior to October 1, 2020. <br />j) Opioid Defendant means any defendant (including but not limited to Teva <br />Pharmaceutical Industries Ltd., Allergan Finance, LLC, Allergan Limited, CVS <br />Health Corporation, CVS Pharmacy, Inc., Walgreen Co., Walmart Inc., Johnson & <br />Johnson, Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Cardinal Health, Inc., <br />AmerisourceBergen Corporation, and McKesson Corporation) named in a lawsuit <br />seeking damages, abatement, or other remedies related to or caused by the opioid <br />public health crisis in any lawsuit brought by any state or local government on or <br />before October 1, 2020. <br />3. General Terms <br />This agreement is subject to the requirements of the Teva Settlement Agreement, as well as <br />applicable law, and the Teva Settlement Agreement governs over any inconsistent provision of <br />this CA Teva Allocation Agreement. Terms used in this CA Teva Allocation Agreement have <br />the same meaning as in the Teva Settlement Agreement unless otherwise defined herein. <br />Pursuant to Section VIII(E)(1) of the Teva Settlement Agreement, (a) all Settlement Fund <br />payments will be used for Opioid Remediation, except as allowed by Section VIII(C) of the Teva <br />Settlement Agreement; and (b) at least seventy percent (70%) of Settlement Fund payment <br />amounts will be used solely for future Opioid Remediation. <br />4. State Allocation <br />The Settlement Fund payments to California; pursuant to the Teva Settlement Agreement, shall <br />be allocated as follows: 15% to the State Fund; 70% to the Abatement Accounts Fund; and 15% <br />to the Subdivision Fund. For the avoidance of doubt, all funds allocated to California from the <br />a For purposes of clarity, use of the term "California" refers to the geographic territory of <br />California and the state and its local governments therein. The term "State" or "State of <br />California" refers to the State of California as a governmental unit. <br />a <br />
The URL can be used to link to this page
Your browser does not support the video tag.